Recognition of Pioneers in Optogenetics
The Karolinska Institute has awarded the 2026 Nobel Prize in Physiology or Medicine to researchers Karl Deisseroth from Stanford University, Peter Hegemann from Humboldt University of Berlin, and Georg Nagel from the University of Würzburg. Their groundbreaking work has led to the development of optogenetics, a revolutionary technique enabling the precise activation or inhibition of individual nerve cells in a living brain using light.
Per Svenningsson, the chair of the Nobel Committee for Medicine, remarked that this innovative approach “offers opportunities to map the brain in ways we could only have dreamed of before,” enhancing our understanding of one of the most complex organs in the human body and paving the way for new treatments for various neurological disorders.
Experts have noted that this award highlights the intersection of diverse disciplines, as the foundational discoveries leading to optogenetics emerged from microbiological research.
Illuminating the Path: The Alga’s Role
At the turn of the last century, Peter Hegemann began a series of studies aimed at understanding how the unicellular alga Chlamydomonas detects and responds to light, moving towards it at a speed twenty times faster than the human eye. Previous research had documented that Chlamydomonas uses a “eyespot,” a small orange dot on its surface containing retinal, a light-sensitive molecule.
Utilising tiny electrodes, Hegemann measured the electrical signals generated by the alga, gaining insights into the rapid response of this structure. He discovered that the organism could produce an electrical impulse approximately 0.5 milliseconds after receiving light, a response time significantly quicker than the human eye, which requires at least 10 milliseconds to detect light.
Hegemann hypothesised that the light detection mechanism in the alga was simpler than that in the human eye. In the early 1990s, he proposed that a single group of proteins was responsible for light capture and functioned directly as an ion channel. This hypothesis sparked controversy, as, although various ion channels were known, none had previously been documented to respond independently to light.
Unraveling the Mystery of Light Detection
To validate his theory, Hegemann attempted to isolate the light-sensitive proteins from the eyespot. However, upon extraction from their natural environment, these proteins became unstable and deteriorated. Later, a group of Japanese researchers sequenced the complete DNA of Chlamydomonas, allowing Hegemann’s team to identify two genes with characteristics similar to the light-sensitive proteins.
The next step was to assess the function of these genes as ion channels. Hegemann collaborated with Georg Nagel, who devised an experimental model by introducing copies of each identified gene into different groups of frog eggs. The eggs began to produce the corresponding proteins, which were subsequently located in the cell membranes. Nagel then conducted a second experiment, illuminating the produced proteins to test their function.
It was during this process that Nagel discovered both groups of proteins acted as ion channels that opened in response to light, which he named channelrhodopsin-1 and channelrhodopsin-2. The latter would prove particularly significant for the subsequent development of optogenetics.
From Microbiology to Neuroscience: A Nobel Journey
The mechanism was directly demonstrated; when channelrhodopsin-2 was illuminated, the channel opened, allowing positively charged ions to pass through the membrane, generating an electrical signal. Remarkably, this phenomenon occurred in just 0.2 milliseconds, confirming that the extraordinary speed initially observed in Chlamydomonas could be attributed to the action of a light-activated ion channel.
Hegemann and Nagel subsequently validated their hypothesis by introducing the channelrhodopsin-2 gene into human embryonic kidney cells and hamster kidney cells. In both instances, the cells, which typically did not respond to light, gained the ability to generate an electrical signal when illuminated.
They proposed that this protein could be harnessed to generate electrical impulses in cells via light. Mercè Masana, an associate professor at the University of Barcelona, noted that “the discovery of light-activated ion channels and their application to precisely control the activity of specific neurons revolutionised our ability to study the brain and understand how its circuits function.”
The collaborative efforts of Hegemann and Nagel laid the biological foundation for the later development of optogenetics. Hegemann sought a method to control specific nerve cells in a living brain, believing this tool could enhance understanding of brain functions and open new avenues for treating conditions such as depression, autism, and schizophrenia.
Transformative Advances in Neuroscience
Karl Deisseroth’s research focused on developing a tool capable of generating electrical impulses in neurons. After the discovery of channelrhodopsin-2, he requested the DNA encoding the protein from Nagel to introduce it into cultured rat nerve cells. In this experiment, the neurons produced channelrhodopsin-2 and, when exposed to blue light, reacted immediately to generate a neural signal that propagated to other neurons. This pivotal finding in 2005 established channelrhodopsin as a crucial research tool in neuroscience.
In the following years, Deisseroth, Hegemann, and Nagel collaborated to identify additional proteins capable of activating or inhibiting neurons using different light wavelengths, a methodology that was officially termed optogenetics in 2006.
“Thanks to optogenetics, researchers can now activate or inhibit specific neuronal populations simply by illuminating them with light at the correct wavelength. Its significant advantage lies in the genetic precision that allows the expression of light-sensitive proteins solely in neurons sharing a specific molecular identity. This enables us to control their activity while other neurons continue to function normally,” explained Nicolò Accanto, head of the Nonlinear Photonics for Neuroscience group at the Institute of Bioengineering of Catalonia.
The efficacy of this technique has been demonstrated in various experiments. For instance, in 2007, the team introduced the channelrhodopsin-2 gene into a specific type of motor cortex neurons in live mice. When these cells were exposed to light via a fine optical fibre inserted into the brain through a small hole in the skull, the researchers generated a neural signal that allowed them to control the movement of the rodents’ whiskers. The technique has also been successfully employed to study wakefulness and memory.
The Nobel Committee has recognised the journey of these three scientists as the dawn of a new era in neuroscience, opening pathways to explore the workings of the living brain. “Thanks to optogenetics, researchers have been able to uncover neural circuits governing memories, feelings, and specific behaviours relevant to neurological and psychiatric disorders. In clinical medicine, researchers are using this method to attempt to restore vision in individuals with visual impairments,” stated the Nobel Assembly at the Karolinska Institute in a recent announcement.